Form 4 holding
Chief Operating Officer
Phathom Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 785,700
- Estimated value
- $5,176,427
- Report date
- 27 Feb 2025
- Price
- $6.59
- Ownership
- By Trust
Azmi Nabulsi - Chief Operating Officer at Phathom Pharmaceuticals, Inc.
Issuer-level insider activity
- Role
- Chief Operating Officer
- Issuer ticker
- PHAT on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Azmi Nabulsi since 12 Sep 2025
Reported holdings for Azmi Nabulsi in Phathom Pharmaceuticals, Inc.
Form 4 holding
Chief Operating Officer
Phathom Pharmaceuticals, Inc.
- Security class
- Common Stoock
- Shares / value
- 249,567
- Estimated value
- $2,770,194
- Report date
- 31 May 2024
- Price
- $11.10
- Ownership
- Direct
Form 4 holding
Chief Operating Officer
Phathom Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 312,590
- Estimated value
- $2,059,437
- Report date
- 27 Feb 2025
- Price
- $6.59
- Ownership
- Direct
Form 4 holding
Chief Operating Officer
Phathom Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 3,579
- Estimated value
- $23,579
- Report date
- 27 Feb 2025
- Price
- $6.59
- Ownership
- By 401(k)
Form 4 holding
Chief Operating Officer
Phathom Pharmaceuticals, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 55,000
- Estimated value
- Report date
- 27 Feb 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Azmi Nabulsi in Phathom Pharmaceuticals, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.